ASKA Pharmaceutical Hits Day High with 9.4% Surge in Stock Price

ASKA Pharmaceutical Holdings Co., Ltd. has shown significant activity today, with the stock rising by 9.4% as of April 16, 2026. The stock reached an intraday high of JPY 3,020.00, reflecting a strong performance compared to the Japan Nikkei 225, which increased by 2.38% on the same day. Over the past week, ASKA has outperformed the Nikkei 225 with a gain of 7.43%, and its one-month performance stands at an impressive 34.93%, significantly higher than the index's 10.73%. Year-to-date, ASKA has achieved a return of 46.12%, while the Nikkei 225 has returned 18.23%. Despite these positive short-term trends, ASKA's one-year performance of 30.1% lags behind the Nikkei 225's 75.46%. The company's market capitalization is JPY 61,381 million, and it operates within the Pharmaceuticals & Biotechnology sector. Key financial metrics include a P/E ratio of 13.00 and a return on equity of 7.81%. The stock's price-to-book ratio is 0.92, indicating its valuation relative to its book value.